Ulric Jerome

Napo is the UK “tooth-to-tail” pet platform focused on helping millions to be responsible and fulfilled pet parents. We began our journey by building the best insurance product we could think of, and we are now delving deeper into pet care to assist pet parents in ensuring their pets live long, healthy and happy lives. Join us at our ✨free✨ Four Legged Fête, packed full of dog scentwork and interactive games, on October 12th & 13th 👉 https://www.eventbrite.co.uk/e/napos-four-legged-fete-tickets-965827605367?aff=homepage

Enabling electrification for all ⚡

Ancient medicine, modern wellness. Acupuncture, acupressure and organic supplements.

STALICLA SA is a Swiss clinical-stage biopharmaceutical company pioneering Neuro Precision Medicine in neurodevelopmental and neuropsychiatric disorders. With state-of-the-art technology platforms and clinical trials for Autism Spectrum Disorder (ASD) and Substance Use Disorder (SUD), STALICLA is changing the landscape of brain disease treatments. Neurodevelopmental Disorders: To propel neurodevelopmental research, STALICLA have identified patient subgroups and their matching candidate drugs within Autism Spectrum Disorder using its trailblazing, multi-omics DEPI platform. STALICLA is currently preparing Phase 2 trials for STP1, STALICLAs first patient subgroup-matched precision treatment. Substance Use Disorder research: STALICLA is working in partnership with the National Institute of Drug Abuse (NIDA) to advance Phase 3 clinical trials for the most clinically advanced drug candidate for cocaine abuse disorder, STP7. STALICLA is now raising series C funding to advance both verticals. For more information visit: https://stalicla.com.

Contentsquare is the all-in-one experience intelligence platform designed to be easily used by anyone that cares about digital journeys. With our flexible and scalable platform, you quickly get a deep understanding of your customers’ whole online journey.  Our AI-powered insights provide those “ah ha” moments you need to deliver the right digital experiences. You get to work faster and smarter, with the confidence to know what to do next to improve. Leading brands use Contentsquare to grow their business, deliver more customer delight, and move with greater efficiency in a constantly changing world. Our insights optimize the experience on over 1.3 million websites worldwide.

Red Sea Ventures is a early-stage tech, venture firm based in New York City. We invest in seed and early stage technology companies across all industries typically alongside a syndicate of institutional investors. Were a small team thats committed to helping build companies with passionate founders creating solutions to big problems. You can get a sense for our investment process by checking out the portfolio page found at www.redseaventures.com. As always, if you are an entrepreneur working on an exciting idea and would like to get in touch, please drop us a line at hello@redseaventures.com.

Cosmo Connected, a French start-up, has the mission since 2015, to secure all people in mobility (users of bicycles, scooters, motorcycles, and scooters). Cosmo Connected has developed a unique technology, combining hardware and software, which ensures visibility and security for the urban commuter in mobility. Our product ecosystem includes smart lights, augmented visualization systems and a set of connected services accessible from our application. In addition, Cosmo Connected makes its know-how available to micro-mobility players by integrating its technologies at the heart of personal mobility devices. Our goal is to become the leader in connected safety in urban mobility, and to develop connected products and services to meet everyones needs. Our vision is to put our technology at the service of the greatest number and to contribute to making roads safer while promoting the use of soft mobility. commuter in mobility. Cosmo Connected aims to become the leader in connected safety in urban mobility, and to develop connected products and services that adapt to everyones needs.

We believe in FASHION FREEDOM for all of US. As we are. When Universal Standard was just an idea, we spoke about the change we wanted to be – not just the brand we wanted to build. We wanted to create access in a way that has never been done before - with style, quality, and fit as our unwavering guideposts. We wanted to erase arbitrary lines of the past in favor of a future in which all women, regardless of size, could shop from the same rack. We wanted to manifest FASHION FREEDOM in a way that saw all of US, as we are, right now. We are committed to pushing boundaries, leading with innovation, questioning established norms, saying “yes” and then making “yes” happen, being radically authentic, and banding together to build the future. We don’t think outside the box. We believe there is no box. If you’re serious about changing the world, but don’t take yourself too seriously... If you have multiple hats, and aren’t scared to wear more than one… If you think fitting a square peg into a round hole sounds like fun… If you think good can always be great... Join US.

Multiwave Technologies AG is a deep science medical imaging company headquartered in Geneva, Switzerland. Founded in March 2015, Multiwave brings to market a portable MRI device powered by metamaterial technologies and AI software. ​

Napo is the UK “tooth-to-tail” pet platform focused on helping millions to be responsible and fulfilled pet parents. We began our journey by building the best insurance product we could think of, and we are now delving deeper into pet care to assist pet parents in ensuring their pets live long, healthy and happy lives. Join us at our ✨free✨ Four Legged Fête, packed full of dog scentwork and interactive games, on October 12th & 13th 👉 https://www.eventbrite.co.uk/e/napos-four-legged-fete-tickets-965827605367?aff=homepage

Enabling electrification for all ⚡

We are modern value investors focused primarily on transforming services businesses across four sectors in Europe and North America: business services, consumer products and services, financial services and healthcare. We champion founders, entrepreneurs and management teams as they grow and transform their companies, helping them become long-lasting leaders in their industries. Informed by deep industry expertise, we develop theses and then target and invest with intentionality to build portfolios that deliver meaningful customer and shareholder value, and have a positive impact on society. We invest through private equity, structured opportunities, growth & impact, and strategic partnerships, offering flexibility across the capital structure. We take an entrepreneurial, multinational, single-team approach and since inception in 2000, we have invested in more than 100 companies on both sides of the Atlantic. TowerBrook is the first mainstream private equity firm to be certified as a B Corporation, demonstrating leadership in commitment to responsible business practices.

Ancient medicine, modern wellness. Acupuncture, acupressure and organic supplements.

STALICLA SA is a Swiss clinical-stage biopharmaceutical company pioneering Neuro Precision Medicine in neurodevelopmental and neuropsychiatric disorders. With state-of-the-art technology platforms and clinical trials for Autism Spectrum Disorder (ASD) and Substance Use Disorder (SUD), STALICLA is changing the landscape of brain disease treatments. Neurodevelopmental Disorders: To propel neurodevelopmental research, STALICLA have identified patient subgroups and their matching candidate drugs within Autism Spectrum Disorder using its trailblazing, multi-omics DEPI platform. STALICLA is currently preparing Phase 2 trials for STP1, STALICLAs first patient subgroup-matched precision treatment. Substance Use Disorder research: STALICLA is working in partnership with the National Institute of Drug Abuse (NIDA) to advance Phase 3 clinical trials for the most clinically advanced drug candidate for cocaine abuse disorder, STP7. STALICLA is now raising series C funding to advance both verticals. For more information visit: https://stalicla.com.